A Double-blind Randomized Placebo-controlled Study Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac
Clinical trial NCT04034290 · COMPLETED
Trial details
- NCT number
- NCT04034290
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2020-06-30
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.